HK-listed Immunotech hits near 6-week high as China Resources Pharma buys stake

42
7
Favorite

HK-listed Immunotech hits near 6-week high as China Resources Pharma buys stake

Reuters2021-07-21

** Shares of Immunotech Biopharm Ltd , which makes immune cell products for cancer treatment, rise as much as 8.9% to HK$20.80, their highest since June 11

** China Resources Pharmaceutical Group Ltd says unit has agreed to buy 10% of Immunotech from Yue Cheng International Capital, Hualida Development, Ren Xiaojuan and Bei Ni Ltd for HK$799.66 mln ($102.9 mln)

** Says unit has agreed to buy 51.46 mln existing shares of Beijing-based Immunotech at HK$15.54 each, further developing its business in cellular immunotherapy

** Shares of China Resources Pharmaceutical rise 1.8%

** The Hong Kong Hang Seng Commerce & Industry Index slips 0.8%, and the healthcare index falls 1%

** The Hang Seng China Enterprises Index slides 0.7%, and the benchmark index eases 0.5%

** By last close, Immunotech shares up 71.7% this year

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（7）

诗迷
·2021-07-21
Like and comment
Reply
1
Report
WeiKeong
·2021-07-21
Pls like
Reply
1
Report
IsaacYap90
·2021-07-21
Ok
Reply
Like
Report
carene6666
·2021-07-21
Like
Reply
6
Report
Fold Replies
- WeiKeong:
  Like
  2021-07-21
  Reply
  Report
Kimmikim
·2021-07-21
Like pls
Reply
7
Report
Fold Replies
- JT888:
  ?
  2021-07-21
  Reply
  Report
- carene6666:
  [微笑]
  2021-07-21
  Reply
  Report
Kimmikim
·2021-07-21
Wow
Reply
6
Report
Ahmay
·2021-07-21
Wow. This is the next wave?
Reply
6
Report
Fold Replies
- Kimmikim:
  Ok
  2021-07-21
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2153619165?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-21 13:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2153619165","market":"hk","top_or_hot":-1,"title":"HK-listed Immunotech hits near 6-week high as China Resources Pharma buys stake","media":"Reuters","content":"<p>** Shares of Immunotech Biopharm Ltd , which makes immune cell products for cancer treatment, rise as much as 8.9% to HK$20.80, their highest since June 11</p>\n<p>** China Resources Pharmaceutical Group Ltd says unit has agreed to buy 10% of Immunotech from Yue Cheng International Capital, Hualida Development, Ren Xiaojuan and Bei Ni Ltd for HK$799.66 mln ($102.9 mln)</p>\n<p>** Says unit has agreed to buy 51.46 mln existing shares of Beijing-based Immunotech at HK$15.54 each, further developing its business in cellular immunotherapy</p>\n<p>** Shares of China Resources Pharmaceutical rise 1.8%</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index slips 0.8%, and the healthcare index falls 1%</p>\n<p>** The Hang Seng China Enterprises Index slides 0.7%, and the benchmark index eases 0.5%</p>\n<p>** By last close, Immunotech shares up 71.7% this year</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed Immunotech hits near 6-week high as China Resources Pharma buys stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed Immunotech hits near 6-week high as China Resources Pharma buys stake\n</h2>\n\n<h4 class=\"meta\">\n\n2021-07-21 13:35 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Shares of Immunotech Biopharm Ltd , which makes immune cell products for cancer treatment, rise as much as 8.9% to HK$20.80, their highest since June 11\n** China Resources Pharmaceutical Group Ltd ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":null,"article_id":"2153619165","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2153619165","pubTimestamp":1626845708,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares of Immunotech Biopharm Ltd , which makes immune cell products for cancer treatment, rise a","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药","CAAS":"中汽系统","06978":"永泰生物-B"},"translate_title":"香港上市的免疫技术公司创近6周新高华润医药收购股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":0.9,"06978":0.9,"CAAS":0.9},"content_text":"** Shares of Immunotech Biopharm Ltd , which makes immune cell products for cancer treatment, rise as much as 8.9% to HK$20.80, their highest since June 11\n** China Resources Pharmaceutical Group Ltd says unit has agreed to buy 10% of Immunotech from Yue Cheng International Capital, Hualida Development, Ren Xiaojuan and Bei Ni Ltd for HK$799.66 mln ($102.9 mln)\n** Says unit has agreed to buy 51.46 mln existing shares of Beijing-based Immunotech at HK$15.54 each, further developing its business in cellular immunotherapy\n** Shares of China Resources Pharmaceutical rise 1.8%\n** The Hong Kong Hang Seng Commerce & Industry Index slips 0.8%, and the healthcare index falls 1%\n** The Hang Seng China Enterprises Index slides 0.7%, and the benchmark index eases 0.5%\n** By last close, Immunotech shares up 71.7% this year","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":176999622,"gmtCreate":1626851719466,"gmtModify":1703479283904,"author":{"id":"3586570953514754","authorId":"3586570953514754","name":"诗迷","avatar":"https://static.tigerbbs.com/ede7919964a05a6754d4489382883c39","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176999622","repostId":2153619165,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176057986,"gmtCreate":1626848873445,"gmtModify":1703479238118,"author":{"id":"3574809268346931","authorId":"3574809268346931","name":"WeiKeong","avatar":"https://static.tigerbbs.com/5495c1f2e5e2d6067ea4add6d0b105c5","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176057986","repostId":2153619165,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176027997,"gmtCreate":1626847784419,"gmtModify":1703479223706,"author":{"id":"3583568085402852","authorId":"3583568085402852","name":"IsaacYap90","avatar":"https://static.tigerbbs.com/40f66d0266826bb209ee22688d7bbde5","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176027997","repostId":2153619165,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176026282,"gmtCreate":1626847508146,"gmtModify":1703479219714,"author":{"id":"3581685137027755","authorId":"3581685137027755","name":"carene6666","avatar":"https://static.tigerbbs.com/9df897fb7cd3e029d1ce54ce071a3c2b","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/176026282","repostId":2153619165,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5280733,"gmtCreate":1626848867804,"gmtModify":1663231256543,"authorId":3574809268346931,"author":{"id":3574809268346931,"authorId":3574809268346931,"name":"WeiKeong","avatar":"https://static.tigerbbs.com/5495c1f2e5e2d6067ea4add6d0b105c5","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.25","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176026282,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"EN"},{"id":176065385,"gmtCreate":1626846665347,"gmtModify":1703766322184,"author":{"id":"3587034039252261","authorId":"3587034039252261","name":"Kimmikim","avatar":"https://static.tigerbbs.com/5245979307e650b7f31c25334244e006","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/176065385","repostId":2153619165,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5280604,"gmtCreate":1626847493006,"gmtModify":1663231254126,"authorId":3560310978208055,"author":{"id":3560310978208055,"authorId":3560310978208055,"name":"JT888","avatar":"https://static.tigerbbs.com/401d4c74d73fbfc36934d21a5f23ac78","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176065385,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"},{"id":5280607,"gmtCreate":1626847529823,"gmtModify":1635224694539,"authorId":3581685137027755,"author":{"id":3581685137027755,"authorId":3581685137027755,"name":"carene6666","avatar":"https://static.tigerbbs.com/9df897fb7cd3e029d1ce54ce071a3c2b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176065385,"type":1,"supId":0,"prevId":0,"content":"[微笑]","text":"[微笑]","html":"[微笑]"}],"langContent":"EN"},{"id":176062143,"gmtCreate":1626846589482,"gmtModify":1703766321216,"author":{"id":"3587034039252261","authorId":"3587034039252261","name":"Kimmikim","avatar":"https://static.tigerbbs.com/5245979307e650b7f31c25334244e006","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176062143","repostId":2153619165,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176063116,"gmtCreate":1626846281335,"gmtModify":1703766315229,"author":{"id":"3582027522385523","authorId":"3582027522385523","name":"Ahmay","avatar":"https://static.tigerbbs.com/1038369a4dfd68fd7bfe651bb0a9622f","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Wow. This is the next wave?","listText":"Wow. This is the next wave?","text":"Wow. This is the next wave?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/176063116","repostId":2153619165,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5280533,"gmtCreate":1626846600854,"gmtModify":1663231254837,"authorId":3587034039252261,"author":{"id":3587034039252261,"authorId":3587034039252261,"name":"Kimmikim","avatar":"https://static.tigerbbs.com/5245979307e650b7f31c25334244e006","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176063116,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":42,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}